The Latin America, Middle East and Africa Burn Ointment Market is expected to witness market growth of 6.6% CAGR during the forecast period (2020-2026).
The hydrocolloid dressing is a burn care accessory that have inner gel-forming agents and outer flexible water-resistant layer that is used for moderate burn wounds. Burn care products & accessories also include burn dressings, moist burn pads, water gel spray, hydrogel, Non-adherent pads, and hydrocolloid, collagen, and alginate dressings. For higher degree burns treatment wound dressing, medication, therapy, and surgery are done to control pain, prevent infection, and removing dead cells.
The advancement in technology, favorable reimbursement policies, and the increasing incidence of burn cases are the major factors responsible for market growth. In addition to it, increasing awareness about various treatment options and the availability of cost-effective ointment is also expected to fuel the market over the forecast period.
The risk of hospital-acquired infections (HAI) is one of the major challenges that is faced by patients with burn injuries. The highest revenue in the burn injury treatment market is generated from hospitals. The healthcare providers in hospitals and clinics are providing topical treatments in order to reduce the incidences of hospital-acquired infections.
Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
Scope of the Study
Market Segments covered in the Report:
By Depth of Burn
By Product
By End Use
By Country
Companies Profiled
Unique Offerings from the Publisher
The hydrocolloid dressing is a burn care accessory that have inner gel-forming agents and outer flexible water-resistant layer that is used for moderate burn wounds. Burn care products & accessories also include burn dressings, moist burn pads, water gel spray, hydrogel, Non-adherent pads, and hydrocolloid, collagen, and alginate dressings. For higher degree burns treatment wound dressing, medication, therapy, and surgery are done to control pain, prevent infection, and removing dead cells.
The advancement in technology, favorable reimbursement policies, and the increasing incidence of burn cases are the major factors responsible for market growth. In addition to it, increasing awareness about various treatment options and the availability of cost-effective ointment is also expected to fuel the market over the forecast period.
The risk of hospital-acquired infections (HAI) is one of the major challenges that is faced by patients with burn injuries. The highest revenue in the burn injury treatment market is generated from hospitals. The healthcare providers in hospitals and clinics are providing topical treatments in order to reduce the incidences of hospital-acquired infections.
Based on Depth of Burn, the market is segmented into Minor Burns, Partial Thickness Burns and Full Thickness Burns. Based on Product, the market is segmented into Topical Antibiotics, Silver, Iodine and Other Products. Based on End Use, the market is segmented into Clinics, Hospitals and Other End Use. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, ConvaTec Group PLC, Smith & Nephew PLC, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Perrigo Company PLC, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Morepen Limited and Mankind Pharma Ltd.
Scope of the Study
Market Segments covered in the Report:
By Depth of Burn
- Minor Burns
- Partial Thickness Burns
- Full Thickness Burns
By Product
- Topical Antibiotics
- Silver
- Iodine
- Other Products
By End Use
- Clinics
- Hospitals
- Other End Use
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Johnson and Johnson
- ConvaTec Group PLC
- Smith & Nephew PLC
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Perrigo Company PLC
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Dr. Morepen Limited
- Mankind Pharma Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Burn Ointment Market by Depth of Burn
Chapter 4. LAMEA Burn Ointment Market by Product
Chapter 5. LAMEA Burn Ointment Market by End Use
Chapter 6. LAMEA Burn Ointment Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Johnson and Johnson
- ConvaTec Group PLC
- Smith & Nephew PLC
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Perrigo Company PLC
- Sun Pharmaceutical Industries Ltd.
- Cipla Limited
- Dr. Morepen Limited
- Mankind Pharma Ltd.
Methodology
LOADING...
